{"entities":{"Q9815":{"pageid":13976,"ns":120,"title":"Item:Q9815","lastrevid":205736,"modified":"2020-05-21T15:45:11Z","type":"item","id":"Q9815","labels":{"en":{"language":"en","value":"Borjesson PK, et al. Clin. Cancer Res. (2003) cited as Ref 552 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9815$2DA3544F-6554-455E-95A6-AE28653A982F","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9815$272D90A7-6168-4E4F-ABCC-14D903983E41","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Borjesson PK","type":"string"},"datatype":"string"},"type":"statement","id":"Q9815$17C6FBE5-2FC7-4D2E-A327-B510B3D942D5","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"14506195","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9815$35D0B464-588A-4052-A107-190FEA1401AA","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2003-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9815$83B17937-8DCC-4546-B4B8-DC0669FA518E","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Clin. Cancer Res.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9815$AF99D10F-688D-49BF-BFD8-A0A17F977000","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"9","type":"string"},"datatype":"string"},"type":"statement","id":"Q9815$7985C713-F16F-44E0-AFCF-DDCE6A90969A","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9815$B39226EB-50C6-49F9-9015-642631C88958","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"3961s-3972s","type":"string"},"datatype":"string"},"type":"statement","id":"Q9815$7D5035DE-BF49-4E5A-84BE-F6C45C3F2A76","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Borjesson PK, et al. Clin. Cancer Res. (2003) cited as Ref 552 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Borjesson_PK,_et_al._Clin._Cancer_Res._(2003)_cited_as_Ref_552_in_DOI:_10.1038/s41392-020-0110-5"}}}}}